Antiviral activity of hop constituents against a series of DNA and RNA viruses

Antiviral Research

Volumn 61, Issue 1, 2004, Pages 57-62

  Buckwold, Victor E ^a   Wilson, Richard J H ^b   Nalca, Aysegul ^a   Beer, Brigitte B ^a   Voss, Thomas G ^a   Turpin, Jim A ^a,e   Buckheit III, Robert W ^a,f   Wei, Jiayi ^a   Wenzel Mathers, Michelle ^a   Walton, Eve M ^a,c   Smith, Robert J ^d   Pallansch, Melanie ^a   Ward, Priscilla ^a   Wells, Jay ^a   Chuvala, Lara ^a   Sloane, Sandra ^a   Paulman, Robin ^a   Russell, Julie ^a   Hartman, Tracy ^a   Ptak, Roger ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b SS Steiner Inc   (United States)

^c ISU US Biotech   (United States)

^d Hops Extract Corporation of America   (United States)

^e HowPin International Consulting   (United States)

^f TherImmune Research Corporation   (United States)

Author keywords

Antiviral; Hops; iso Xanthohumol; iso Acid; Lead compounds; Xanthohumol

Indexed keywords

ANTIVIRUS AGENT; HOP EXTRACT; ISOXANTHOHUMOL; PLANT EXTRACT; PROPIOPHENONE DERIVATIVE; UNCLASSIFIED DRUG; VEGETABLE OIL; XANTHOHUMOL;

ANIMAL; ANTIVIRAL ACTIVITY; ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE VIRAL DIARRHEA VIRUS; CELL LINE; CHEMISTRY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA VIRUS; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG PURIFICATION; DRUG SCREENING; DRUG SYNTHESIS; EXPERIMENTAL MODEL; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMULUS; HUMULUS LUPULUS; IC 50; INFLUENZA VIRUS A; INFLUENZA VIRUS B; ISOMER; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; RNA VIRUS; VIRUS; VIRUS REPLICATION; YELLOW FEVER FLAVIVIRUS;

BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS; HUMULUS; HUMULUS LUPULUS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RHINOVIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SIMPLEXVIRUS; YELLOW FEVER VIRUS;

EID: 10744229195     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00155-4     Document Type: Article

References (17)

1. Broderick, H.M. (Ed.), 1977. The Practical Brewer: A Manual for the Brewing Industry, 2nd ed. Master Brewers Association of the Americas, Madison, WI.
2. Buckwold, V.E., Wei, J., Wenzel-Mathers, M., Russell, J., 2003a. Synergistic in vitro interactions between alpha interferon and ribavirin against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication. Antimicrob. Agents Chemother. 47, 2293-2298.
3. Buckwold, V.E., Beer, B.E., Donis, R.O., 2003b. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res., in press.
4. Gerhauser C., Alt A., Heiss E., Gamal-Eldeen A., Klimo K., Knauft J., Neumann I., Scherf H.-R., Frank N., Bartsch H., Becker H. Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 1:2002;959-969.
5. Honma Y., Tobe H., Makishama M., Yokoyama A., Okabe-Kado J. Induction of differentiation of myelogeneous leukemia cells by humulone, a bitter in the hop. Leukemia Res. 22:1998;605-610.
6. Korba B.F., Milman G. A cell culture assay for compound which inhibit hepatitis B virus replication. Antiviral Res. 15:1991;217-228.
7. Krosky P.M., Borysko K.Z., Nassiri M.R., Devivar R.V., Ptak R.G., Davis M.G., Biron K.K., Townsend L.B., Drach J.C. Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus. Antimicrob. Agents Chemother. 46:2002;478-486.
8. Milligan S.R., Kalita J.C., Heyerick A., Rong H., De Cooman L., De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 84:1999;2249-2252.
9. Neve, R.A., 1991. The Cultivated Hop. In Hops. Chapman & Hall, London (Chapter 2).
10. Palamand S.R., Aldenhoff J.M. Bitter tasting compounds of beer. Chemistry and taste properties of some hop resin compounds. J. Agric. Food Chem. 21:1973;535-543.
11. Pfenninger, H., Schur, F., Anderegg, P., 1979. In: Pollock, J.R.A. (Ed.), Composition and Analysis of Hops and Derived Products. Part D. Brewing Science, Academic Press, London.
12. Simpson W.J., Smith R.W. Factors affecting antibacterial activity of hop compounds and their derivatives. J. Appl. Bacteriol. 72:1992;327-334.
13. Stevens J.F., Miranda C.L., Buhler D.L., Deinzer M.L. Chemistry and biology of hop flavonoids. J. Am. Soc. Brewing Chem. 56:1998;136-145.
14. Stevens J.F., Taylor A.W., Clawson I.F., Deinzer M.I. Fate of xanthohumol and related prenylflavonoids from hops to beer. J. Agric. Food Chem. 47:1999a;2421-2428.
15. Stevens J.F., Taylor A.W., Deinzer M.L. Quantitative analysis of xanthohumol and related prenylflavenoids in hops and beer by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A. 832:1999b;97-107.
16. Tagashira M., Watanabe M., Uemitsu N. Antioxidative activity of hop bitter acids and their analogues. Biosci. Biotech. Biochem. 59:1995;740-742.
17. Weislow O.S., Kiser R., Fine D.L., Bader J.P., Shoemaker R.H., Boyd M.R. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J. Natl. Cancer Inst. 81:1989;577-586.